A new study shows promising results for treating certain cancers with immunotherapy and completely avoiding surgery, radiation and chemotherapy.

Proceeds benefit the MSK Cancer Health Equity Research and Care Initiative, dedicated to advancing equitable cancer care for ...

Union members will benefit from Memorial Sloan Kettering’s lifesaving discoveries ... Executive Director at a large New York City trade union From the moment we partnered with MSK Direct, we ...

New research shows 92% of cancer patients stayed cancer-free for two years after immune-based therapy, potentially avoiding ...

CNN anchor and breast cancer patient Sara Sidner, Dr. Vinod Balachandran, and Novartis U.S. president Victor Bulto discussed ...

Philadelphia-based Jefferson Health has named Michael Harrington its new executive vice president and CFO. Mr. Harrington joins the system from New York City-based Memorial Sloan Kettering Cancer ...

HealthCare has opened a new cancer center in partnership with New York City-based Memorial Sloan Kettering Cancer Center. Through the partnership, physicians at the Hartford HealthCare Fairfield ...

According to the results of a new study in the New England Journal of Medicine, 92% of patients who took this drug were cancer-free after two years.

Flaks, commenting on the prevalence of cancer diagnoses in Connecticut, said the new center will “dramatically accelerate” bringing innovation to Connecticut, and Hartford HealthCare hopes eventually ...

A first-of-its-kind cancer center opened in Fairfield on Friday. Hartford Healthcare hosted a grand opening ceremony for the ...

The executive is joining Jefferson, the largest health system in eastern Pennsylvania, from Memorial Sloan Kettering Cancer Center.